DYNLRB1 and small cell lung carcinoma: Sunday et al. found that bombesin-like peptides (BLP, a mitogen for normal bronchial epithelial cells and small cell lung carcinomas) was highly expressed in fetal lung tissue, and CD10 inhibition could strengthen the BLP-responsive small cell lung carcinomas (Sunday et al., 1992).